Company · Biotech and pharma
Blood collection tubes using recombinant ecarin for rapid serum
Melbourne, VIC
Every investor coverage indicates participated in a round Q-SERABlood collection tube technology raised.
Investors whose own portfolio pages list Q-SERABlood collection tube technology, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Stoic Venture Capital | its portfolio page ↗ |
| Stoic Venture Capital | its portfolio page ↗ |
Companies Q-SERABlood collection tube technology acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Q-SERABlood collection tube technology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Q-Sera's rapid-clotting blood tube technology has gone to market in Japan via Terumo's VenoJect II launch; the Melbourne startup's backers include MRCF, Uniseed and the UniQuest Extension Fund.